These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33418007)

  • 1. Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series.
    Guo Q; Zheng Y; Lin J; Xu Y; Hu C; Zong J; Lu T; Xu H; Chen B; Liang Q; Xiao Y; Pan J; Lin S
    Radiother Oncol; 2021 Mar; 156():251-257. PubMed ID: 33418007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The individualized delineation of clinical target volume for primary nasopharyngeal carcinoma based on invasion risk of substructures: A prospective, real-world study with a large population.
    Wang X; Huang N; Yip PL; Wang J; Huang R; Sun Z; Kang D; He Q; Deng X; Zhao C; Chua MLK; Han F
    Radiother Oncol; 2024 May; 194():110154. PubMed ID: 38367938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and toxicity of individualized intensity-modulated radiotherapy based on the tumor extension patterns of nasopharyngeal carcinoma.
    Lin L; Yao JJ; Zhou GQ; Guo R; Zhang F; Zhang Y; Xu L; Zhang LL; Lin AH; Ma J; Sun Y
    Oncotarget; 2016 Apr; 7(15):20680-90. PubMed ID: 26980744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
    Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
    J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma.
    Kong F; Ying H; Du C; Huang S; Zhou J; Chen J; Sun L; Chen X; Hu C
    Radiat Oncol; 2014 Feb; 9():60. PubMed ID: 24552293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
    Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
    Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
    Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
    BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study.
    Guo Q; Lu T; Huang W; Xu H; Zhang Q; Xiao Y; Zhong J; Xie H; Chen J; Zong J; Gong X; Pan J; Li J; Lin S
    Radiother Oncol; 2024 Mar; 192():110086. PubMed ID: 38184146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update report of nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy and hypothesis of the optimal margin.
    Lin S; Pan J; Han L; Guo Q; Hu C; Zong J; Zhang X; Lu JJ
    Radiother Oncol; 2014 Mar; 110(3):385-9. PubMed ID: 24560755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure patterns and prognostic factors for cervical node-negative nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Wu Z; Wang L; Xie DH; Lv SW; Su Y; Shi YR
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):330-337. PubMed ID: 33079493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of long-term survival outcomes and failure patterns of patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy: a retrospective analysis.
    Zhao W; Lei H; Zhu X; Li L; Qu S; Liang X
    Oncotarget; 2016 Dec; 7(52):86914-86925. PubMed ID: 27894100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
    Yang H; Chen X; Lin S; Rong J; Yang M; Wen Q; Shang C; He L; Ren P; Xu S; Zhang J; Liu Q; Pang H; Shi X; Fan J; Sun X; Ma D; Tan B; Zhang T; Zhang L; Hu D; Du X; Zhang Y; Wen S; Zhang X; Wu J
    Radiother Oncol; 2018 Jan; 126(1):37-42. PubMed ID: 28864073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative dosimetric study of two strategies of intensity-modulated radiotherapy in nasopharyngeal cancer.
    Chen SW; Yang SN; Liang JA; Shiau AC; Lin FJ
    Med Dosim; 2005; 30(4):219-27. PubMed ID: 16275564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
    Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy.
    He YX; Wang Y; Cao PF; Shen L; Zhao YJ; Zhang ZJ; Chen DM; Yang TB; Huang XQ; Qin Z; Dai YY; Shen LF
    Chin J Cancer; 2016 Nov; 35(1):96. PubMed ID: 27852284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes and prognostic factors of 695 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Wang W; Feng M; Fan Z; Li J; Lang J
    Biomed Res Int; 2014; 2014():814948. PubMed ID: 25162028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized clinical target volume delineation and efficacy analysis in unilateral nasopharyngeal carcinoma treated with intensity-modulated radiotherapy (IMRT): 10-year summary.
    Xie DH; Wu Z; Li WZ; Cheng WQ; Tao YL; Wang L; Lv SW; Lin FF; Cui NJ; Zhao C; Ma J; Huang SM; Lu TX; Han YQ; Su Y
    J Cancer Res Clin Oncol; 2022 Aug; 148(8):1931-1942. PubMed ID: 35486182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.